Not recruiting
DNA mismatch repair protein gene mutation+7
Not recruitingRegistered drugNo placebo
Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy
Registered drugNo placebo
- Disease:DNA mismatch repair protein gene mutationRectal cancer+6
- Substances:AtezolizumabMycobaterium Obuense, Strain Nctc 13365, Heat-Killed
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
- Sponsor:AIO-Studien gGmbH
